- Long-Term Effectiveness of First-Line Antiretroviral Theraphy in a Cohort of HIV-1 Infected PatientsJordi Navarro-, Mercadé; Manuel, Crespo; Vicenç, Falcó; Eva Van, Den EyndeJournal of Antivirals and Antiretrovirals, 2012, 04(02).
- Integrase Strand Transfer Inhibitor Start or Switch Impacts Learning in Women With HIVJane A., O'Halloran; Kunbo, Wang; Amanda B., Spence; Dionna W., Williams; Raha, Dastgheyb; Kathryn C., Fitzgerald; Asante R., Kamkwalala; Pauline M., Maki; Anjali, Sharma; Deborah R., Gustafson; Joel, Milam; Kathleen M., Weber; Adaora A., Adimora; Igho, Ofotokun; Margaret A., Fischl; Deborah, Konkle-Parker; Cecile D., Lahiri; Anandi N., Sheth; Yanxun, Xu; Leah H., RubinJournal of Acquired Immune Deficiency Syndromes, 2021, 86(5): 593-599.
- Dual raltegravir/etravirine combination in virologically suppressed HIV-1-infected patients on antiretroviral therapyRuxandra, Calin; Luc, Paris; Anne, Simon; Gilles, Peytavin; Marc, Wirden; Luminita, Schneider; Marc-Antoine, Valantin; Roland, Tubiana; Rachid, Agher; Christine, KatlamaAntiviral Therapy, 2012, 17(8): 1601-1604.被引 13
期刊论文
Advances in Long-Acting Agents for the Treatment of HIV Infection
4被引21阅读
